Hemab Therapeutics Holdings, Inc.
 
 
 
 
公司概覽
業務類別 Biotechnology
業務概覽 Hemab Therapeutics Holdings Inc is a clinical-stage biotechnology company developing therapies for the treatment of blood coagulation disorders. It focuses on discovering, developing, and commercializing treatments for conditions such as Glanzmann thrombasthenia, Factor VII deficiency, and von Willebrand disease. Its flagship candidate, sutacimig (HMB-001), is a bispecific antibody currently in clinical trials for the prophylactic treatment of Glanzmann thrombasthenia and Factor VII deficiency. The company has one operating segment, engaged in the research and development of prophylactic therapeutics for bleeding disorders.
公司地址 101 Main Street, Suite 1220, Cambridge, MA, USA, 02142
電話號碼 +1 617 553-3952
傳真號碼 --
公司網頁 https://www.hemab.com
員工數量 72
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Benny Sorensen, M.D.,PhD Director, President and Chief Executive Officer -- 10/04/2026
Ms. Catherine Madigan, M.D. Chief Medical Officer -- 10/04/2026
Dr. Ananthram Sreenivasa Murthy, M.Sc. Chief Operating Officer -- 10/04/2026
Mr. Mads Behrndt-Eriksen, M. Sc. Chief Financial Officer, Chief Accounting Officer and General Manager -- 10/04/2026
 
董事會成員
董事會 職務 更新日期
Dr. John M. Maraganore,PhD Chairman of the Board 10/04/2026
Dr. Akshay K. Vaishnaw, M.D.,PhD Director 10/04/2026
Ms. Linda C. Bain Director 10/04/2026
Dr. Benny Sorensen, M.D.,PhD Director, President and Chief Executive Officer 10/04/2026
Ms. Keli Walbert Director 24/09/2026
 
所屬ETF (更新日期: 07/11/2026 04:21)
代號 名稱 佔比% ▼ 持有日期
WSMLiShares MSCI World Small-Cap ETF0.003%30/10/2026
ITWOProShares Russell 2000 High Income ETF0.002%30/10/2026
URTYProShares UltraPro Russell20000.002%30/10/2026
MSMLiShares MSCI USA Small-Cap ETF0.001%30/10/2026
UWMProShares Ultra Russell20000.001%30/10/2026
AVUQAvantis U.S. Quality ETF0.001%30/10/2026
PWSPacer WealthShield ETF0.0003%30/10/2026
HDGProShares Hedge Replication0.0001%30/10/2026
RBProshares Russell 2000 Dynamic BufferETF0.00001%30/10/2026
HQHabrdn Healthcare Investors<0.000001%31/07/2026
HQLabrdn Life Sciences Investors<0.000001%31/07/2026
THQabrdn Healthcare Opportunities<0.000001%31/07/2026
THWabrdn World Healthcare<0.000001%31/07/2026
TNXTT. Rowe Price Innovation Leaders ETF<0.000001%01/10/2026
  1   2  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.